Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-29 @ 1:21 AM
Study NCT ID:
NCT01097057
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2010-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-26
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-30
First Submit QC Date:
None
Study First Post Date:
2010-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-26
Results First Submit QC Date:
None
Results First Post Date:
2017-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-28
Last Update Post Date:
2018-01-23
Last Update Post Date Type:
ACTUAL